19 May. 2022 18:00
Limiting pain in animals: an ethical issue and a major requirement in today's society where animal welfare is gaining increasing importance.
What pain management encompasses
Pain is an unpleasant sensory and emotional experience. It is subjective and based primarily on the feelings of the patient, making it even more difficult to quantify and qualify. Nevertheless it becomes a real issue in companion animals and is also a source of particular attention in production animals, where it is associated with inflammation and economic losses.
Our philosophy with respect to pain
The mission that Vetoquinol has set itself with regard to its "Pain" division is to propose solutions to prevent, treat and manage pain, regardless of the type of pain and its origin, with products, services and training, in order to make daily practice easier. A daily challenge for which the Group is constantly investigating innovative solutions and implementing both human and financial resources so that pain is no longer experienced as a fatality.
Key Vetoquinol brands for pain and inflammation
Tolfedine CS® and Tolfine® (livestock), Cimalgex® (treatment of acute and chronic pain for dogs), and Flexadin® and Caniviton® (joint support in osteoarthritis for cats and dogs), Diurizone® (livestock).
Warning: these web pages are intended for English speaking users, excluding users based on French territory. To access information for French residents, please visit the dedicated website: www.vetoquinol.fr. These pages are general information pages of the Vetoquinol Group. Products ranges are tailored to accommodate local demand and regulatory requirements which may change from one country to the next. For further information about the products in accordance with applicable national regulations, please refer to the Vetoquinol website for your country . The information provided depends on national registrations. The technical information is only accessible to authorised persons.